Silence Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	82.03	121.33	68.78	66.32	99.42	37.53
Short-Term Investments	20.16	26	-	19.75	-	13.67
Cash & Short-Term Investments	102.19	147.33	68.78	86.07	99.42	51.2
Cash Growth	-40.77%	114.21%	-20.09%	-13.43%	94.18%	15.20%
Accounts Receivable	0.03	0.97	0.29	1.11	0.45	40.07
Other Receivables	22.15	24.4	22.44	18	9.39	4.83
Total Trade Receivables	22.18	25.37	22.73	19.11	9.84	44.9
Other Current Assets	9.26	14.66	11.63	11.79	7.46	8.35
Total Current Assets	133.63	187.37	103.14	116.97	116.72	104.45
Net Property, Plant & Equipment	1.85	1.98	2.31	2.66	2.63	1.54
Other Intangible Assets	0.3	0.31	0.36	0.39	0.03	0.02
Goodwill	10.61	9.39	9.98	9.69	10.26	11.11
Other Long-Term Assets	0.4	3.59	3.65	0.34	0.41	0.41
Total Assets	146.79	202.64	119.44	130.05	130.05	117.54
Accounts Payable	16.99	16.4	15.82	15.28	14.58	11.2
Current Portion of Leases	0.09	0.12	0.23	0.54	0.19	0.47
Unearned Revenue	0.3	0.31	6.57	10.72	5.74	23.3
Total Current Liabilities	17.38	16.82	22.62	26.55	20.51	34.97
Long-Term Leases	-	-	0.12	-	-	-
Other Long-Term Liabilities	55.25	51.79	74.99	76.8	98.02	70.19
Total Long-Term Liabilities	55.25	51.79	75.11	76.8	98.02	70.19
Total Liabilities	72.73	68.61	97.73	103.35	118.53	105.15
Common Stock	10.29	10.29	-7.56	6.52	6.07	5.69
Additional Paid-in Capital	617.65	609.56	-399.43	336.15	304.82	255.52
Accumulated Other Comprehensive Income	3.07	11.78	-2.48	2.52	2.08	3.03
Retained Earnings	550.8	474.04	387.77	-318.5	-301.45	-251.86
Total Common Shareholders' Equity	1,182	1,106	-21.7	26.7	11.53	12.39
Shareholders' Equity	74.06	134.02	43.41	0	0	0
Total Liabilities & Equity	146.79	202.64	141.14	103.35	118.53	105.15
Total Debt	0.09	0.12	0.35	0.54	0.19	0.47
Net Cash (Debt)	102.11	147.22	68.44	85.53	99.24	50.73
Net Cash Growth	-30.64%	115.12%	-19.99%	-13.81%	95.60%	15.14%
Net Cash Per Share	1.44	3.18	1.84	2.66	-	2.05
Book Value	1,182	1,106	-21.7	26.7	11.53	12.39
Book Value Per Share	16.68	23.91	-0.59	0.83	-	0.50
Tangible Book Value	1,171	1,096	-32.05	16.63	1.23	1.25
Tangible Book Value Per Share	16.53	23.70	-0.86	0.52	-	0.05

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.